If you got a question, look no further.
We post the most common questions
in our FAQ section.
Please fill in the form below to receive a Free Sample of the Report.
Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.The profile contains critical company information including:- Business description - A detailed description of the company's operations and business divisions.- Corporate strategy - Analyst's summarization of the company's business strategy.- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.- Company history - Progression of key events associated with the company.- Major products and services - A list of major products, services and brands of the company.- Key competitors - A list of key competitors to the company.- Key employees - A list of the key executives of the company.- Executive biographies - A brief summary of the executives' employment history.- Key operational heads - A list of personnel heading key departments/functions.- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.HighlightsNovozymes A/S (Novozymes) is a biotech company that produces and sells industrial enzymes and microorganisms. The company develops, produces and distributes enzymes for detergent, technical, food and feed industries. It supplies a range of microorganisms for use in agriculture, industrial cleaning and wastewater treatment. Novozymes provides various biopharmaceutical ingredients for the pharmaceutical industry. The company caters products to various industries such as household care, agriculture, biopharmaceuticals, bioenergy, food and beverages, pulp and paper, leather, wastewater and textiles. It has operational presence in various countries such as Denmark, China, India and the US among other countries. Novozymes is headquartered in Bagsvaerd, Denmark.Novozymes AS Key Recent DevelopmentsJun 27,2017: DONG Energy: One of the largest power stations in Denmark can phase out coalMar 23,2017: Residues from Novo Nordisk and Novozymes to be converted into biogasDec 05,2016: Monsanto Company and Novozymes launch corn inoculant Acceleron B-300 SATJun 30,2016: Novozymes to deliver enzymes for Dong Energy's REnescience plant in UKJun 29,2016: Novozymes and DONG Energy enter into agreement on biological waste sortingKey benefits of buying this profile include:You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.Gain key insights into the company for academic or business research.- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.Note: Some sections may be missing if data is unavailable for the company
Table of ContentsTable of Contents 3List of Tables 4List of Figures 4Section 1 - About the Company 5Novozymes A/S - Key Facts 5Novozymes A/S - Key Employees 6Novozymes A/S - Key Employee Biographies 7Novozymes A/S - Major Products and Services 8Novozymes A/S - History 9Novozymes A/S - Company Statement 12Novozymes A/S - Locations And Subsidiaries 14Head Office 14Other Locations & Subsidiaries 14Section 2 - Company Analysis 17Novozymes A/S - Business Description 17Novozymes A/S - Corporate Strategy 18Novozymes A/S - SWOT Analysis 19SWOT Analysis - Overview 19Novozymes A/S - Strengths 19Novozymes A/S - Weaknesses 20Novozymes A/S - Opportunities 21Novozymes A/S - Threats 22Novozymes A/S - Key Competitors 23Section 3 - Company Financial Ratios 24Financial Ratios - Capital Market Ratios 24Financial Ratios - Annual Ratios 25Performance Chart 28Financial Performance 28Financial Ratios - Interim Ratios 29Financial Ratios - Ratio Charts 30Novozymes A/S, Recent Deals Summary 31Section 4 - Company's Recent Developments 32Jun 27, 2017: DONG Energy: One of the largest power stations in Denmark can phase out coal 32Mar 23, 2017: Residues from Novo Nordisk and Novozymes to be converted into biogas 33Dec 05, 2016: Monsanto Company and Novozymes launch corn inoculant Acceleron B-300 SAT 35Jun 30, 2016: Novozymes to deliver enzymes for Dong Energy's REnescience plant in UK 36Jun 30, 2016: Novozymes to deliver enzymes for Dong Energy's REnescience plant in UK 37Jun 30, 2016: Novozymes to deliver enzymes for Dong Energy's REnescience plant in UK 38Jun 29, 2016: Novozymes and DONG Energy enter into agreement on biological waste sorting 39Jan 19, 2016: Group Financial Statement for 2015: Novozymes 40Jan 19, 2016: Novozymes separates its biopharma activities to form independent company 41Section 5 - Appendix 42Methodology 42Ratio Definitions 42About GlobalData 46Contact Us 46Disclaimer 46List of TablesNovozymes A/S, Key Facts 5Novozymes A/S, Key Employees 6Novozymes A/S, Key Employee Biographies 7Novozymes A/S, Major Products and Services 8Novozymes A/S, History 9Novozymes A/S, Subsidiaries 14Novozymes A/S, Key Competitors 23Novozymes A/S, Ratios based on current share price 24Novozymes A/S, Annual Ratios 25Novozymes A/S, Annual Ratios (Cont...1) 26Novozymes A/S, Annual Ratios (Cont...2) 27Novozymes A/S, Interim Ratios 29Novozymes A/S, Recent Deals Summary 31Currency Codes 42Capital Market Ratios 42Equity Ratios 43Profitability Ratios 43Cost Ratios 44Liquidity Ratios 44Leverage Ratios 45Efficiency Ratios 45List of FiguresNovozymes A/S, Performance Chart (2012 - 2016) 28Novozymes A/S, Ratio Charts 30